📊 Score Breakdown
Offering Ability
85
Cash Runway
85
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
57%
💰 Capital Raise
73%
• Low cash runway: 6 months remaining
• Active shelf registration ($250M, 58% of market cap)
🔁 Convertible Conversion
60%
• Major convertible overhang: 220% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
15%
• Score already CRITICAL (83/100) — events likely imminent
💹 Market Data
Market Cap$429.30M
Shares Outstanding29.32M
Float22.65M
Cash$33.03M
Debt$5.23M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 5.4% shares (2025Q4 vs prior)
56 institutional holders · 7.83M shares
#1
Bleichroeder LP
1.63M shares
#2
ROYAL BANK OF CANADA
965.4K shares
#3
MORGAN STANLEY
807.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.70M
Days to Cover4.1
% of Float7.5%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2024
424B5
ATM
Mar 02, 2026
8-K
8K EVENT
Mar 02, 2026
424B5
ATM
Feb 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for DUOT
📊 DUOT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 DUOT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.